Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
复制标题
DOI：
10.1167/iovs.10-5392
复制
发表时间：
2010-11-01
影响因子：
4.4
通讯作者：
Wong, Wai T.
中科院分区：
文献类型：
--
作者：
Edelhauser, Henry F.;Rowe-Rendleman, Cheryl L.;Wong, Wai T.
ARVO 2009年夏季眼科研究会议（SERC 2009）眼科药物输送系统于2009年7月31日和8月1日在马里兰州贝塞斯达的国立卫生研究院（NIH）举行。这次会议提供了一个机会，聚集了来自学术眼科和眼科制药行业的200多名专家，包括实验室研究人员和临床医生，讨论将眼部药物输送到后段的输送系统的最新进展，以及这些系统如何成功地用于商业产品。为期两天的会议包括以下九场会议：（1）眼部解剖学和药物转运的眼部屏障，（2）药物递送中的玻璃体液，（3）玻璃体内药物递送，（4）视网膜疾病的经巩膜药物递送，（5）视网膜药物治疗的临床前基准，（6）用于评估药物递送系统的动物模型，（7）视网膜疾病的局部治疗，（8）临床试验，和（9）来自摘要的新数据。并由辉瑞眼科研究所会议赞助。1 SERC 2009由Cheryl L. Rowe-Rendleman，PhD（Omar Consulting Group，LLC），Michael R.罗宾逊，医学博士（艾尔建公司），和亨利F. Edelhauser，PhD（Emory University）. Edelhauser和Paul A. Sieving，MD，PhD，以介绍性评论开始了会议。
The ARVO 2009 Summer Eye Research Conference (SERC 2009) on Ophthalmic Drug Delivery Systems was held July31 and August 1, 2009, at the National Institutes of Health (NIH) in Bethesda, Maryland. The conference provided an opportunity to gather a diverse group of more than 200 experts from both academic ophthalmology and the ophthalmic pharmaceutical industry, including laboratory researchers and clinicians, to discuss recent advances in delivery systems that convey ocular drugs to the posterior segment and how these systems might be successfully used in commercial products. The two-day meeting comprised the following nine sessions:(1) eye anatomy and ocular barriers to drug transport,(2) the vitreous humor in drug delivery,(3) intravitreal drug delivery,(4) transscleral drug delivery for retinal diseases,(5) preclinical benchmarks for retinal drug therapy,(6) animal models for evaluating drug delivery systems,(7) topical therapy for retinal diseases,(8) clinical trials, and (9) new data from abstracts.This meeting was co-sponsored by the Association in Research in Vision and Ophthalmology (ARVO) and the NIH to expand and continue ongoing collaborative interchange and synergic endeavors that were addressed at an earlier conference, held May 4 and 5, 2007, and sponsored by the Pfizer Ophthalmics Research Institute Conference. 1 SERC 2009 was organized by Cheryl L. Rowe-Rendleman, PhD (Omar Consulting Group, LLC), Michael R. Robinson, MD (Allergan Inc.), and Henry F. Edelhauser, PhD (Emory University). Edelhauser and Paul A. Sieving, MD, PhD, started off the meeting with introductory comments.